Development of the Drug and Alcohol Respiratory Health Test
- Sponsor
- King's College London
- Study ID
- NCT06921278
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Asthma
- Bronchitis
- COPD
- Lung Cancer
- Obstructive Sleep Apnea
- Pneumonia
- Respiratory Disease
- Substance-Related Disorders
- Tuberculosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this study is to develop a brief Drug and Alcohol Respiratory Health Test (DARHT) and offer it for routine use in clinical assessment and medical reviews
Key Dates
- First listed
- Apr 10, 2025
- Start date
- Apr 15, 2025
- Status verified
- Mar 2025
- Primary completion
- Nov 11, 2025
- Completion
- Nov 11, 2025
Study Design
- Enrollment
- 260 participants (estimated)
Primary Outcome Measure
A brief respiratory health screening questionnaire [ Time Frame: Day 1 and Day 3-7 ]
Central Contacts
- John Marsden, B.Sc., M.Sc., PhD, PgDiP CBT+44 02078365454
- Francesca Small, Msc+ 44 020 3228 1500
Find similar trials
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Evaluation for NCI Surgery Branch Clinical Research ProtocolsRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland